REVIEW
- 1 January 1993
- journal article
- research article
- Published by Walter de Gruyter GmbH in Biological Chemistry Hoppe-Seyler
- Vol. 374 (1-6) , 227-236
- https://doi.org/10.1515/bchm3.1993.374.1-6.227
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Wild-type p53 binds to the TATA-binding protein and represses transcription.Proceedings of the National Academy of Sciences, 1992
- Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.Proceedings of the National Academy of Sciences, 1992
- Germline Mutations of the p53 Tumor-Suppressor Gene in Children and Young Adults with Second Malignant NeoplasmsNew England Journal of Medicine, 1992
- Prevalence and Spectrum of Germline Mutations of the p53 Gene among Patients with SarcomaNew England Journal of Medicine, 1992
- Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product.Proceedings of the National Academy of Sciences, 1991
- Genetic basis for p53 overexpression in human breast cancer.Proceedings of the National Academy of Sciences, 1991
- Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.Proceedings of the National Academy of Sciences, 1991
- Wild-type p53 can inhibit oncogene-mediated focus formation.Proceedings of the National Academy of Sciences, 1989
- Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen.Proceedings of the National Academy of Sciences, 1983
- Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.Proceedings of the National Academy of Sciences, 1979